Research News and Media
Current News

Jun 25, 2024
Quality Medical Research: Spotlight on Life Changing Medications!
See what drives the passion for companies like QMR on Advancements with Ted Danson: Spotlight on Clinical Research for Life-Changing Medications!

Oct 1, 2024
Understanding NASH and Fatty Liver Disease: Causes, Symptoms, and Emerging Treatments
We talk about fatty liver disease, which is the buildup of fat in the liver. NASH is a more serious condition where there is also inflammation in the liver...

Oct 1, 2024
Transforming N.A.S.H. Treatment: Participate in Our Clinical Study
We talk about a clinical trial for a new treatment for NASH (non-alcoholic steatohepatitis). The goal is to find a medication that can help reverse...


What's New Related to Drugs
FDA Drugs | November 13, 2026
Read Original Article →FDA Approves First Drug to Treat Adults with Primary Membranous Nephropathy
FDA Drugs | November 13, 2026
Read Original Article →Tumor Treating Fields and Quality of Life in Advanced Pancreatic Adenocarcinoma
JAMA Network Open | November 12, 2026
Read Original Article →Clinician Training, Text Messages, and HPV Vaccination Among Children
JAMA Network Open | November 12, 2026
Read Original Article →Racial and Ethnic Differences in Availability of Uterine Cancer Clinical Trials
JAMA Network Open | November 12, 2026
Read Original Article →FDALabel: Full-Text Search of Drug Product Labeling
FDA Drugs | November 12, 2026
Read Original Article →Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Preschoolers
JAMA Network Open | November 11, 2026
Read Original Article →Procalcitonin- and Presepsin-Guided Antibiotics for Sepsis in Preterm Infants
JAMA Network Open | November 11, 2026
Read Original Article →Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible S aureus
JAMA Network Open | November 11, 2026
Read Original Article →Cefazolin vs Cloxacillin for Methicillin-Susceptible S aureus Bacteremia
JAMA Network Open | November 11, 2026
Read Original Article →Bisphosphonates vs Denosumab After Low-Trauma Fractures
JAMA Network Open | November 10, 2026
Read Original Article →ctDNA in Oligoprogressive Prostate Cancer Treated With Stereotactic Radiotherapy
JAMA Network Open | November 10, 2026
Read Original Article →Home Visit Intervention to Reduce Unintentional Child Injury in Rural China
JAMA Network Open | November 10, 2026
Read Original Article →Trial-Collected vs Parent-Reported Race and Ethnicity in a Pediatric Cancer Trial
JAMA Network Open | November 10, 2026
Read Original Article →The Seductive Short-Term Effects of Denosumab
JAMA Network Open | November 10, 2026
Read Original Article →Child Injury Prevention via Community-Based Delivery in Rural China
JAMA Network Open | November 10, 2026
Read Original Article →Estimation of mRNA-1283 vs BNT162b2 COVID-19 Vaccine Effectiveness
JAMA Network Open | November 10, 2026
Read Original Article →CBER Listening Meeting: Patient and Care Partner Perspectives on Early Enrollment into Gene Therapy Clinical Trials for Rare Diseases
FDA Biologics | November 10, 2026
Read Original Article →Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus
FDA Biologics | November 10, 2026
Read Original Article →Early-Phase IND Protocol Recommendations for Solid Tumors; Draft Guidance for Industry
FDA Biologics | November 10, 2026
Read Original Article →Loberamisal for Acute Ischemic Stroke
JAMA Latest Research | November 9, 2026
Read Original Article →Inhaled Corticosteroids and Sickle Cell Disease in Adults Without Asthma
JAMA Network Open | November 9, 2026
Read Original Article →Ibuprofen Use and Acute Kidney Injury Among Hospitalized Adults
JAMA Network Open | November 9, 2026
Read Original Article →Testing the 40% to 60% Influenza Vaccine Effectiveness Heuristic
JAMA Network Open | November 9, 2026
Read Original Article →Vaccine and Related Biological Product Guidances
FDA Biologics | November 9, 2026
Read Original Article →Delivering Answers and Hope for Rare Disease Families
FDA Biologics | November 9, 2026
Read Original Article →Approved Cellular and Gene Therapy Products
FDA Biologics | November 9, 2026
Read Original Article →Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement - 10/22/2020
FDA Biologics | November 9, 2026
Read Original Article →Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement - 12/10/2020
FDA Biologics | November 9, 2026
Read Original Article →Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement - 12/17/2020
FDA Biologics | November 9, 2026
Read Original Article →Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Announcement - 02/26/2021
FDA Biologics | November 9, 2026
Read Original Article →Vaccines and Related Biological Products Advisory Committee June 10, 2021 Meeting Announcement - 06/10/2021
FDA Biologics | November 9, 2026
Read Original Article →MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication
FDA MedWatch | November 8, 2026
Read Original Article →Inforatio Technique and Foot Ulcer Closure Among Patients With Diabetes
JAMA Network Open | November 8, 2026
Read Original Article →Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
FDA MedWatch | October 20, 2026
Read Original Article →Feel free to contact us to learn more.
Contact Us
(615) 835-4720
studies@thegidocs.com
Address
330 Wallace Road Suite 103 Nashville, TN 37211

March 24, 2024

